Endometrial Advancement After Rec or u-HCG Triggering
Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate any potential advantages of replacing human
chorionic gonadotropin (uhCG) with recombinant human chorionic gonadotropin (recHCG) for
final oocyte maturation with regard to Ovarian hyperstimulation syndrome
(OHSS)pathophysiology, endometrium receptivity and embryo quality and clinical pregnancy.